Our results revealed that cells with SNX16 overexpression were much more sensitive to 10058‐F4 treatment and inhibition of c‐Myc could significantly block SNX16 overexpression‐mediated proliferation of CRC cells. The gene discussed is SNX16; the disease is colorectal carcinoma.